Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

TIMOLOL MALEATE

TIMOLOL MALEATE

Standard Dose
0.5%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview TIMOLOL MALEATE is listed in Drugs@FDA under application 204912 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient TIMOLOL MALEATE Form and strength SOLUTION;OPHTHALMIC - 0.5% Sponsor AKORN INC Submission history Latest submission status date: 2015-09-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview TIMOLOL MALEATE is listed in Drugs@FDA under application 204912 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient TIMOLOL MALEATE Form and strength SOLUTION;OPHTHALMIC - 0.5% Sponsor AKORN INC Submission history Latest submission status date: 2015-09-24 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.